Clinical Trial Update: Clinical Evaluation of BW430C in Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating BW430C in epilepsy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BW430C

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2012-09-17